human AGXT shRNA silencing AAV

Name 
AAV-h-AGXT-shRNA
Cat No 
shAAV-200585
Availability
6-8 weeks
Categories
AAV, shRNA-Silencing

This is an AAV expressing shRNA for silencing of Human AGXT.

shAAV-200585
AAV-h-AGXT-shRNA

Ready-to-use AAV expressing shRNA for silencing of Human AGXT (alanine-glyoxylate aminotransferase). Available with optional GFP reporter or cell-specific promoter.

Request a Quote

Product Details

AAV Serotype
Available in AAV1, AAV2, AAV3, AAV5, AAV6, AAV8, AAV9, AAV-DJ, AAV-DJ8, AAV-DJ9 and other wildtype/synthetic AAV capsids
AAV ITR
AAV2
Promoter
U6 ()
Reporter
eGFP (default), optional CFP, YFP, RFP, mCherry
Storage Buffer
PBS/5% Glycerol
Viral Backbone
Recombinant AAV

Gene Reference Data

Alternate Names
AGT; AGT1; AGXT1; PH1; SPAT; SPT; TLH6
Description (Vector)
AGXT is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria.
Gene ID
189
Gene Name (Vector)
alanine-glyoxylate aminotransferase
Gene Symbol
AGXT
HGNC ID
HGNC:341
ORF Size (aa)
1179
ORF Size (bp)
1179 bp
RefSeq ID
NM_000030
RefSeq Synonyms
NM_000030, BC132819,
Species
human
UniGene ID
Hs.144567

About Storage Conditions

All our viral products should be kept at -80°C. At this temperature, the virus will remain stable for 6-12 months (and in some cases, up to 2 years). Once thawed, the product can be stored at 4°C for 2-3 weeks without significant loss of biological activity. We recommend aliquoting your vectors into low protein binding tubes upon receipt. This helps avoid repeated freeze-thaw cycles, as well as prevent loss of virus. To maintain accurate titer, aliquot in at least 20ul per tube.